Robert LaPolla is listed as a director on 2 SEC Form D filings by 1 issuer between Sep 2014 and Oct 2016: Allele Biotechnology & Pharmaceuticals, Inc. (San Diego, CA — biotechnology — 2014–2016; $11M reported sold to 4 investors).
What this means One deal on file with the SEC. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Jiwu Wang (2 shared filings), Lin Yang (2 shared filings), Quishi Fu (2 shared filings) and Shao-Chung Tsai (1 shared filing).
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Robert. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — 8 court cases matching the name, 6 bankruptcy cases matching the name listed in Key records below.
What this means 14 records came back, including 1 court case still open — open cases can take years and cost money. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 2 public filings for Robert LaPolla and found 1 difference: Form D filed 28 days after the first sale.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.